Skip to main content
Fig. 4 | Antimicrobial Resistance & Infection Control

Fig. 4

From: Network meta-analysis and pharmacoeconomic evaluation of antibiotics for the treatment of patients infected with complicated skin and soft structure infection and hospital-acquired or ventilator-associated penumonia

Fig. 4

Network meta-analysis of clinical cure in cSSSI in mITT population. Comparisons should be read from left to right. The safety estimate is located at the intersection of the column-defining treatment and the row-defining treatment. Significant results are in bold and underlined. cSSSI, complicated skin and soft structure infection. mITT, modified intention-to-treat population. JNJ-Q2, a novel fluoroquinolone. VAN, vancomycin. LIN, linezolid. CEF1, ceftaroline. CEF2, ceftobiprole. SXT/RIT, trimethoprim/sulfamethoxazole plus rifampicin. ORI, oritavancin. DAL, dalbavancin. DAP, daptomycin. TEL, telavancin. TIG, tigecyline. TEI, teicoplanin. OMA, omadacycline. FA, fusidic acid. JNJ-Q2, a novel fluoroquinolone. TED, tedizolid. OR, odds ratio. CI, confidence interval

Back to article page

Antimicrobial Resistance & Infection Control

ISSN: 2047-2994

Contact us